Stay informed with the latest litigation news. Explore now

IP Verse

Salix Pharmaceuticals, Inc. V. Mylan Pharmaceuticals, Inc. - 1:25-cv-00024

Explore the details of the Salix Pharmaceuticals, Inc. V. Mylan Pharmaceuticals, Inc. case under case number 1:25-cv-00024 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-00024
Filing Date
Mar 26, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Applications (ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Mylan Pharmaceuticals, Inc. -
Salix Pharmaceuticals, Inc. -
Bausch Health Ireland Ltd. -
Alfasigma S.P.A. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 5, 2025***SEALED*** ORDER granting 35 Motion Signed by Chief District Judge Thomas S Kleeh on 6/5/2025. Copy to counsel of record. (mas) (Entered: 06/05/2025)PACER Document
Jun 16, 2025CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. Defendant Mylan Pharmaceuticals Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1). (Hissam, Michael) (Entered: 06/16/2025)PACER Document
Jun 17, 2025CERTIFICATE OF SERVICE by Alfasigma S.P.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd. certifying service of Plaintiffs' Rule 26(a)(1) Initial Disclosures. (Higginbotham, Daniel) (Entered: 06/17/2025)PACER Document
Jun 18, 2025Joint MOTION for Extension of Time to File Response/Reply Joint Motion to Extend Briefing Deadlines for Plaintiff's Motion to Dismiss Counterclaim III [ECF No. 34] by Mylan Pharmaceuticals, Inc.. (Hissam, Michael) (Entered: 06/18/2025)PACER Document
Jun 19, 2025Proposed Stipulated Discovery Confidentiality Order by Mylan Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit Exhibit A)(Hissam, Michael) (Entered: 06/19/2025)PACER Document
Jun 23, 2025CERTIFICATE OF SERVICE by Alfasigma S.P.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. certifying service of Plaintiffs' Disclosure of Asserted Claims and Infringement Contentions and Production of Documents. (Higginbotham, Daniel) (Entered: 06/23/2025)PACER Document
Jun 25, 2025MEMORANDUM in Support of Motion for Leave to File Mylan's Brief in Opposition to Plaintiffs' Motion to Dismiss Under Seal by Mylan Pharmaceuticals, Inc. . (Hissam, Michael) (Entered: 06/25/2025)PACER Document
Jun 27, 2025RESPONSE in Opposition re 34 MOTION to Dismiss Counterclaim III filed by Mylan Pharmaceuticals, Inc.. (Hissam, Michael) (Entered: 06/27/2025)PACER Document
Jun 27, 2025Exhibits to Other Document re 45 Response in Opposition to Motion filed by Mylan Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4)(Hissam, Michael) (Entered: 06/27/2025)PACER Document
Jul 2, 2025***SEALED***ORDER granting 43 Motion. Signed by Chief District Judge Thomas S Kleeh on 7/2/2025. Copy to counsel of record. (mas) (Entered: 07/02/2025)PACER Document
Jul 2, 2025STIPULATED DISCOVERY CONFIDENTIALITY ORDER. Signed by Chief District Judge Thomas S Kleeh on 7/2/2025. (mas) (Entered: 07/02/2025)PACER Document
Jul 2, 2025ORDER GRANTING JOINT MOTION FOR EXTENSION (ECF NO. 40 ). Mylan's Brief in Opposition to Plaintiffs' Motion to Dismiss (ECF No. 45 ) is DEEMED TIMELY FILED and Plaintiffs' deadline to file any reply briefing in support of its Motion to Dismiss Counterclaim III is EXTENDED to July 8, 2025. Signed by Chief District Judge Thomas S. Kleeh on 07/02/2025. (snc) (Entered: 07/02/2025)PACER Document
Jul 8, 2025CERTIFICATE OF SERVICE by Alfasigma S.P.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd. certifying service of Plaintiffs' Amended Rule 26(a)(1) Initial Disclosures. (Higginbotham, Daniel) (Entered: 07/08/2025)PACER Document
Jul 8, 2025Memorandum in Support re 34 MOTION to Dismiss Counterclaim III Reply Memorandum in Further Support of Plaintiffs' Motion to Dismiss Counterclaim III filed by Alfasigma S.P.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Higginbotham, Daniel) (Entered: 07/08/2025)PACER Document
Jul 9, 2025***SEALED*** ORDER. Signed by Chief District Judge Thomas S. Kleeh on 7/9/2025. (jb) (Copy to counsel of record) (Entered: 07/09/2025)PACER Document
Jul 10, 2025CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. Defendants Noninfringement Contentions. (Hissam, Michael) (Entered: 07/10/2025)PACER Document
Jul 10, 2025CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. Defendants Initial Invalidity Contentions. (Hissam, Michael) (Entered: 07/10/2025)PACER Document
Jun 5, 2025MOTION to Dismiss Counterclaim III by Alfasigma S.P.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd.. (Attachments: # 1 Redacted Memorandum in Support of Plaintiffs' Motion to Dismiss Counterclaim III)(Higginbotham, Daniel) (Entered: 06/05/2025)Attachment
Jul 18, 2025CERTIFICATE OF SERVICE by Alfasigma S.P.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. certifying service of Plaintiffs' Disclosure of Proposed Terms for Construction. (Higginbotham, Daniel) (Entered: 07/18/2025)PACER Document